The FDA Law Blog
DECEMBER 8, 2022
Food and Drug Administration (FDA) issued two guidance documents, one draft and one final, on food allergen labeling requirements. 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g.,
Pharmaceutical Technology
MAY 17, 2023
Marketing Packages Taking part in the Excellence Awards offer your company many benefits including being able to tell the market, new and prospective clients about your achievement. For full details on the benefits, the scale of our audience and the marketing packages on offer please download the RESEARCH GUIDE.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 5, 2023
Revised for 2023, the Parenteral Drug Association (PDA) has published an update to its Technical Report No. Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types.
European Pharmaceutical Review
DECEMBER 19, 2023
The document was adopted by EMA’s Management Board at its December meeting. Work has already begun with the ongoing public consultation on the AI reflection paper, open until the end of 2023. The plan was prepared by the Big Data Steering Group (BDSG), a joint initiative between HMA and EMA.
European Pharmaceutical Review
JANUARY 25, 2024
These standardised documents provide meticulously curated and scientifically approved information. References European Commission, (26 April 2023). European Commission, (28 June 2023) “Access to essential services: key challenges for the most vulnerable – report” Euractiv (26 September 2023). Euractiv (6 October 2023).
Pharmaceutical Technology
APRIL 14, 2023
Although the organisation previously shared a draft version of the report in February, the revised document features new details on the drugs’ potential fair pricing. Obeticholic acid will be in the spotlight when an approval package for its use in NASH will be discussed at a Gastrointestinal Drugs Advisory Committee meeting on May 19.
The Checkup by Singlecare
FEBRUARY 23, 2024
And as of December 2023, BCBS covers nearly 118 million people , which is about 1 in 3 Americans. per package, which is equivalent to about $16,188 per year. How to check whether your BCBS plan covers Wegovy The first step in determining if Wegovy is covered by your plan is to check your plan documents.
Expert insights. Personalized for you.
59 
Let's personalize your content